eye disease: A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma. [NCIt:C26767]
Other specified and unspecified disorders of eye and adnexa
DOID EFO Endpoint Browser PheWeb
H7_EYEADNEXOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1475 |
4. Check minimum number of eventsNone |
1475 |
5. Include endpointsNone |
1475 |
6. Filter based on genotype QC (FinnGen only) |
1475 |
Control definitions (FinnGen only)
- Control exclude
- H7_EYEOTH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other specified and unspecified disorders of eye and adnexa
based on the number of shared cases.
Similar with more cases:
- Other disorders of eye and adnexa
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 12111 | 7188 | 4811 |
| Only index persons | 9719 | 5826 | 3893 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.18 | 0.21 | 0.13 |
| Only index persons | 0.19 | 0.21 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 47.98 | 51.02 | 43.22 |
| Only index persons | 43.84 | 47.44 | 38.46 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1475 | 943 | 532 |
| Unadjusted period prevalence (%) | 0.29 | 0.32 | 0.23 |
| Median age at first event (years) | 48.25 | 47.13 | 50.23 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1320
- Matched controls
- 13199
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
4642.9
323.0
1013
9
37898
ICD-8 Finland
Other diseases of eye, Disease of eyeball, ocular muscle and orbit NEC
+∞
237.9
221
*
R4110
NOMESCO Finland
Physiotherapy
4.0
107.0
581
2177
XCK10
NOMESCO Finland
Photography of fundus of eye
5.3
87.0
298
686
H57.8
ICD-10 Finland
Other specified disorders of eye and adnexa
296.0
82.6
83
*
XCK00
NOMESCO Finland
Perimetry
6.7
81.9
227
399
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.8
79.5
301
766
XF400
NOMESCO Finland
ECG with 12 standard connections
3.5
62.1
347
1223
ZXA00
NOMESCO Finland
Right side
2.7
52.9
473
2253
WX002
NOMESCO Finland
Sedation and analgesia
3.0
50.9
367
1523
H57.1
ICD-10 Finland
Ocular pain
11.6
49.4
94
87
XCD10
NOMESCO Finland
Electrophysiological examination of eye
9.7
49.3
103
114
ZXA05
NOMESCO Finland
Left side
2.7
49.1
444
2107
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.3
44.7
631
3741
H04.10
ICD-10 Finland
Dry eye syndrome
3.5
41.8
213
679
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.6
38.3
188
579
ZXA10
NOMESCO Finland
Bilateral
2.6
36.8
329
1511
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.7
36.2
282
1195
H53.1
ICD-10 Finland
Subjective visual disturbances
4.3
34.0
134
339
H02AB07
ATC
prednisone; oral
2.7
32.7
260
1108
XA800
NOMESCO Finland
Neuropsychological investigation
5.7
32.3
96
179
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
30.7
279
1279
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
29.7
333
1693
S01GX01
ATC
cromoglicic acid; ophthalmic
2.3
29.5
311
1534
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
29.3
407
2279
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.2
28.2
363
1961
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
27.8
419
2420
R4120
NOMESCO Finland
Occupational therapy
3.8
26.4
119
339
R51.80
ICD-10 Finland
Headache
2.5
26.2
234
1052
N02AX02
ATC
tramadol; systemic, rectal
1.9
26.1
580
3863
Z71.8
ICD-10 Finland
Other specified counselling
2.1
25.8
338
1828
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
24.1
497
3194
H46
ICD-10 Finland
Optic neuritis
17.6
23.2
36
21
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
5.5
22.0
66
125
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
21.8
237
1170
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.5
20.6
174
752
EB1AA
SPAT
NA
3.6
20.4
95
278
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
19.8
158
664
N03AX16
ATC
pregabalin; oral
1.9
19.4
326
1916
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
19.4
287
1608
SPAT1324
SPAT
Screening procedure
0.3
19.0
43
1334
WX140
NOMESCO Finland
Parabulbar anesthesy
3.7
18.9
85
242
XCD20
NOMESCO Finland
Photoangiography of eye
6.0
18.9
52
89
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
18.7
366
2267
J01DA01
ATC
[U] cefalexin; systemic
1.7
18.6
830
6593
J01MA02
ATC
ciprofloxacin; systemic
1.7
18.5
506
3485
H02.4
ICD-10 Finland
Ptosis of eyelid
4.8
18.1
61
132
A02BA02
ATC
ranitidine; systemic
1.9
17.8
282
1614
J01DA06
ATC
[U] cefuroxime; systemic
2.1
17.7
224
1174
WX110
NOMESCO Finland
Local anesthesy
1.7
17.6
865
7004
WX892
NOMESCO Finland
Monitored bed care
2.8
17.4
117
443
S01EA03
ATC
apraclonidine; ophthalmic
8.3
17.3
38
47
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
4.5
17.2
61
140
M79.6
ICD-10 Finland
Pain in limb
1.7
17.1
460
3134
A02BC05
ATC
esomeprazole; systemic
1.7
17.1
522
3695
N06AB04
ATC
citalopram; systemic
1.9
16.9
297
1764
H26.2
ICD-10 Finland
Complicated cataract
8.0
16.9
38
49
TAB00
NOMESCO Finland
Lumbar puncture
3.5
16.8
79
234
A02BC02
ATC
pantoprazole; systemic
1.6
16.7
829
6679
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.0
16.6
67
174
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
16.5
168
797
J01FA06
ATC
roxithromycin; oral
1.7
16.4
528
3779
R03AC02
ATC
salbutamol; inhalant
1.6
16.3
676
5176
J05AB11
ATC
valaciclovir; oral
2.2
16.3
185
924
H43.8
ICD-10 Finland
Other disorders of vitreous body
2.5
16.3
129
540
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
16.3
114
442
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.6
16.0
72
206
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
15.9
240
1345
AA1AD
NOMESCO Finland
CT of head and brain
1.8
15.9
300
1823
UJF30
NOMESCO Finland
Ileoscopy through colon
2.4
15.8
144
646
XF600
NOMESCO Finland
Bloodpressure measurement
2.8
15.6
105
399
R42
ICD-10 Finland
Dizziness and giddiness
1.8
15.5
295
1793
A11
ICPC
Chest pain NOS
2.5
15.5
126
534
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.0
15.0
208
1126
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
25.3
14.7
20
8
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
14.7
172
870
RD210
NOMESCO Finland
NA
5.9
14.6
40
69
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.1
14.5
80
267
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
14.5
532
3904
R01AD09
ATC
mometasone; nasal
1.6
14.5
562
4181
N05CF01
ATC
zopiclone; oral
1.7
14.4
423
2926
H25.1
ICD-10 Finland
Senile nuclear cataract
1.7
14.2
315
2005
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
14.2
307
1938
XF402
NOMESCO Finland
ECG with work load test
2.2
14.1
155
763
Z01.7
ICD-10 Finland
Laboratory examination
2.1
14.0
163
820
R03BA02
ATC
budesonide; inhalant
1.9
13.9
242
1424
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
13.8
286
1779
H53.2
ICD-10 Finland
Diplopia
3.8
13.8
58
157
J01FA10
ATC
azithromycin; systemic
1.6
13.7
729
5829
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.6
13.6
99
394
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
13.5
319
2062
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.2
13.5
149
732
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
2.8
13.5
87
321
H02AB06
ATC
prednisolone; systemic
1.6
13.5
580
4400
SPAT1263
SPAT
Sampling
0.6
13.5
270
3978
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
11.6
13.3
24
21
R53
ICD-10 Finland
Malaise and fatigue
1.8
13.2
268
1657
UJH02
NOMESCO Finland
Anoscopy
3.0
13.1
76
263
WX402
NOMESCO Finland
General anaesthesia
1.9
13.0
216
1247
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.8
13.0
85
318
R06AX27
ATC
desloratadine; oral
1.7
12.9
339
2258
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
12.9
126
587
CG2T4
NOMESCO Finland
Topography assessment of cornea
8.6
12.8
27
32
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
12.6
528
3960
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.4
12.6
61
186
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.6
12.6
43
96
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
12.6
117
532
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
12.6
472
3447
J01DB01
ATC
cefalexin; oral
1.6
12.6
1022
8959
S21
ICPC
Skin texture symptom/complaint
2.0
12.3
161
849
R4190
NOMESCO Finland
Nutritional therapy
3.8
12.3
51
137
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
12.3
220
1300
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
5.6
12.3
35
64
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.8
12.2
51
138
SPAT1336
SPAT
Request for examination
3.1
12.1
65
214
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
5.5
12.1
35
65
N30
ICD-10 Finland
Cystitis
2.3
12.1
115
526
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
12.0
149
769
P01AB01
ATC
metronidazole; oral, rectal
1.6
12.0
487
3614
XX9XE
NOMESCO Finland
Other ultrasound examination
8.8
12.0
25
29
N05BA01
ATC
diazepam; systemic, rectal
1.9
11.9
179
995
B01AB04
ATC
dalteparin; parenteral
2.8
11.8
74
271
WX110
SPAT
NA
2.9
11.8
72
257
C07AB07
ATC
bisoprolol; oral
1.5
11.8
558
4289
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.7
11.7
39
85
XCH05
NOMESCO Finland
Eye pressure longterm registration
6.4
11.7
30
48
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
6.4
11.7
30
48
J01AA02
ATC
doxycycline; systemic
1.6
11.7
979
8538
J02AC01
ATC
fluconazole; systemic
1.5
11.7
513
3872
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.6
11.7
40
90
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
11.6
425
3071
S29
ICPC
Skin symptom/complaint other
1.8
11.6
208
1229
XF404
NOMESCO Finland
Ambulatory ECG
2.2
11.6
127
622
F29
ICPC
Eye symptom/complaint other
2.3
11.5
109
498
L17
ICPC
Foot/toe symptom/complaint
1.6
11.5
313
2099
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.2
11.5
116
546
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.1
11.5
139
712
G81.9
ICD-10 Finland
Hemiplegia, unspecified
7.6
11.5
26
35
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.8
11.4
37
79
A02BC01
ATC
omeprazole; systemic
1.6
11.4
346
2387
C01CA24
ATC
epinephrine; parenteral
2.5
11.4
89
370
H40.0
ICD-10 Finland
Glaucoma suspect
2.3
11.3
101
450
J31.0
ICD-10 Finland
Chronic rhinitis
2.3
11.2
110
512
D01
ICPC
Abdominal pain/cramps general
2.0
11.1
140
725
Z31.5
ICD-10 Finland
Genetic counselling
2.7
11.1
75
288
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.4
11.0
39
91
R05
ICD-10 Finland
Cough
1.7
11.0
244
1543
RS222
NOMESCO Finland
NA
5.3
10.9
32
61
ZXC20
NOMESCO Finland
Use of chemical agents
4.3
10.9
39
92
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.1
10.9
132
672
U13
ICPC
Bladder symptom/complaint other
3.2
10.8
57
186
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
2.7
10.8
75
292
R07.0
ICD-10 Finland
Pain in throat
2.4
10.7
88
376
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
3.5
10.7
48
139
R20.2
ICD-10 Finland
Paraesthesia of skin
2.4
10.7
90
389
G35
ICD-10 Finland
Multiple sclerosis
5.2
10.6
32
63
E0000UV
ATC
NA
1.5
10.6
467
3507
R03DC03
ATC
montelukast; oral
1.8
10.6
204
1231
H52.1
ICD-10 Finland
Myopia
3.3
10.6
53
167
S01ED01
ATC
timolol; ophthalmic
2.9
10.6
62
218
N01
ICPC
Headache
2.0
10.5
135
705
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.5
10.4
78
318
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
10.4
154
849
N17
ICPC
Vertigo/dizziness
2.0
10.4
146
791
D11
ICPC
Diarrhoea
1.9
10.3
146
794
M79.1
ICD-10 Finland
Myalgia
1.8
10.3
171
983
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.6
10.3
76
307
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.6
10.3
267
3763
S01AD03
ATC
aciclovir; ophthalmic
2.9
10.2
60
211
L28
ICPC
Limited function/disability (L)
1.8
10.2
199
1208
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
10.2
202
1231
D06
ICPC
Abdominal pain localized other
2.2
10.2
107
513
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
10.1
271
1800
L82
ICD-10 Finland
Seborrhoeic keratosis
1.8
10.1
192
1155
N06AX11
ATC
mirtazapine; oral
1.5
10.1
386
2799
R05
ICPC
Cough
1.6
10.1
265
1749
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
10.1
93
422
N05CF02
ATC
zolpidem; oral
1.7
10.1
212
1314
Z50.1
ICD-10 Finland
Other physical therapy
2.5
10.0
80
336
J01MA06
ATC
norfloxacin; oral
1.8
10.0
187
1120
N03AX09
ATC
lamotrigine; oral
2.7
9.9
66
250
R52.9
ICD-10 Finland
Pain, unspecified
2.1
9.9
112
557
RS220
NOMESCO Finland
NA
5.3
9.9
29
56
R4130
NOMESCO Finland
Speech therapy
4.0
9.9
38
97
J05AB01
ATC
aciclovir; systemic
1.6
9.9
257
1696
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.2
9.8
103
496
G44.2
ICD-10 Finland
Tension-type headache
1.8
9.8
172
1006
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
9.8
234
1506
R06AX22
ATC
ebastine; oral
1.7
9.7
214
1347
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
5.2
9.7
29
57
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.0
9.7
56
195
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
9.7
115
583
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
5.9
9.7
26
45
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
5.9
9.7
26
45
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
3.2
9.6
49
157
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.0
9.6
55
190
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.2
9.6
92
426
A28
ICPC
Limited function/disability NOS
1.8
9.6
177
1055
H20.1
ICD-10 Finland
Chronic iridocyclitis
7.2
9.5
22
31
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.6
9.5
68
271
A07DA03
ATC
loperamide; oral
2.9
9.5
56
199
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
9.5
141
781
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
9.3
67
267
UJD02
NOMESCO Finland
Gastroscopy
2.5
9.3
70
287
L03AB07
ATC
interferon beta-1a; parenteral
9.6
9.3
18
19
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
9.3
143
801
R51
ICD-10 Finland
Headache
2.5
9.2
72
298
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
6.1
9.2
24
40
H16.0
ICD-10 Finland
Corneal ulcer
2.6
9.2
66
263
RS221
NOMESCO Finland
NA
4.8
9.2
29
61
S01EE04
ATC
travoprost; ophthalmic
3.7
9.2
39
109
H43.1
ICD-10 Finland
Vitreous haemorrhage
3.7
9.2
38
104
R03AC03
ATC
terbutaline; inhalant
1.7
9.1
180
1093
WW200
NOMESCO Finland
Immunization
3.3
9.1
44
136
CJ2M4
NOMESCO Finland
Scans and measurement printouts for intraocular lens power calculation
5.9
9.1
24
41
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
9.1
534
4223
S01BC03
ATC
diclofenac; ophthalmic
3.3
9.0
44
137
H57.0
ICD-10 Finland
Anomalies of pupillary function
36.9
9.0
11
*
N06AX21
ATC
duloxetine; oral
1.9
9.0
138
773
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.9
9.0
53
188
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
6.6
9.0
22
34
H54.7
ICD-10 Finland
Unspecified visual loss
7.5
8.9
20
27
3AC01
NOMESCO Finland
NA
6.1
8.9
23
38
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
8.9
178
1086
R06AE07
ATC
cetirizine; oral
1.4
8.8
531
4211
R35
ICD-10 Finland
Polyuria
2.3
8.8
82
375
R01AD08
ATC
fluticasone; nasal
1.5
8.8
329
2366
109
Kela drug reimbursment
Multiple sclerosis
6.0
8.8
23
39
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
8.7
311
2211
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
8.7
346
2520
N05CD07
ATC
temazepam; oral
1.8
8.6
164
986
R2110
NOMESCO Finland
Giving the first information
2.1
8.6
94
460
S01AX11
ATC
[U] ofloxacin; ophthalmic
2.7
8.6
58
222
R07.3
ICD-10 Finland
Other chest pain
1.9
8.6
119
641
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.0
8.5
105
543
R06.0
ICD-10 Finland
Dyspnoea
1.5
8.5
297
2099
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
27.7
8.5
11
*
J01FA01
ATC
erythromycin; systemic
1.7
8.5
169
1031
M03BX02
ATC
tizanidine; oral
1.4
8.5
729
6164
E66.8
ICD-10 Finland
Other obesity
2.4
8.5
73
320
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
8.4
99
500
TND32
NOMESCO Finland
Custom moulded splint, wrist or hand
4.5
8.4
28
63
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
8.4
598
4883
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
8.4
421
3217
J01CA04
ATC
amoxicillin; systemic
1.5
8.4
985
8819
M25.5
ICD-10 Finland
Pain in joint
1.5
8.3
330
2401
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
8.3
90
441
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
10.8
8.3
15
14
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
8.3
105
548
S01ED51
ATC
timolol, combinations; ophthalmic
2.1
8.3
96
482
R03AC13
ATC
formoterol; inhalant
2.3
8.2
74
332
J01FF01
ATC
clindamycin; systemic
1.5
8.1
310
2233
F45.8
ICD-10 Finland
Other somatoform disorders
2.1
8.1
89
438
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
8.1
389
2938
R83
ICPC
Respiratory infection other
1.5
8.1
267
1860
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
11.8
8.1
14
12
H52.2
ICD-10 Finland
Astigmatism
4.5
8.1
27
61
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.0
8.1
101
524
N05BA04
ATC
oxazepam; oral
1.5
8.1
296
2115
M54.5
ICD-10 Finland
Low back pain
1.5
8.1
382
2880
K80
ICPC
Cardiac arrhythmia NOS
2.1
8.0
90
449
J45
ICD-10 Finland
Asthma
1.8
8.0
127
720
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
4.8
8.0
25
53
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
7.9
334
2455
B01AB05
ATC
enoxaparin; parenteral
1.5
7.9
345
2554
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
7.9
215
1428
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.8
7.9
142
840
H53.8
ICD-10 Finland
Other visual disturbances
5.4
7.8
22
41
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
4.4
7.8
27
63
KMAK
NOMESCO Finland
NA
1.4
7.8
597
4911
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
7.8
103
544
K03.64
ICD-10 Finland
Dental calculus supragingival
1.5
7.8
320
2337
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.9
7.8
45
158
IGY99
NOMESCO Finland
Other psychiatric treatment contact
4.5
7.8
26
59
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
7.8
118
657
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
7.8
91
462
114
Kela drug reimbursment
Glaucoma
1.9
7.8
111
608
N02BE01
ATC
paracetamol; systemic, rectal
1.5
7.8
1054
9608
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.9
7.7
45
159
SPAT1342
SPAT
Referral to specialised care
4.6
7.7
25
55
S06.0
ICD-10 Finland
Concussion
1.8
7.7
125
714
R11
ICD-10 Finland
Nausea and vomiting
1.9
7.7
106
572
TQW99
NOMESCO Finland
Other minor procedure on skin
2.3
7.7
66
292
H40.12
ICD-10 Finland
Pigmentary glaucoma
25.2
7.6
10
*
CKC10
NOMESCO Finland
Local photocoagulation of retina
3.8
7.6
30
80
SPAT1249
SPAT
Treatment-related counselling outside office
0.7
7.6
268
3595
H53.4
ICD-10 Finland
Visual field defects
3.4
7.6
35
106
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.4
7.6
35
106
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
4.3
7.5
26
61
L01
ICPC
Neck symptom/complaint
1.7
7.5
167
1051
H02AB04
ATC
methylprednisolone; systemic
1.7
7.5
173
1098
R21
ICPC
Throat symptom/complaint
1.6
7.5
226
1539
N30.0
ICD-10 Finland
Acute cystitis
1.7
7.5
171
1082
R74
ICPC
Upper respiratory infection acute
1.5
7.4
317
2333
A91
ICPC
Abnormal result investigation NOS
2.5
7.4
56
232
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
7.4
358
2700
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
7.4
167
1053
H10.4
ICD-10 Finland
Chronic conjunctivitis
5.6
7.4
20
36
UJF92
NOMESCO Finland
Capsular endoscopy
3.7
7.4
30
82
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.2
7.4
76
363
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.7
7.4
151
928
M01AB05
ATC
diclofenac; systemic, rectal
1.4
7.3
786
6816
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.9
7.3
109
603
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
7.3
76
366
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.7
7.3
152
940
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
3.7
7.3
30
83
M01AH02
ATC
rofecoxib; oral
1.7
7.3
158
986
H01.0
ICD-10 Finland
Blepharitis
2.2
7.3
71
333
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.9
7.2
97
518
M02AA07
ATC
piroxicam; topical
1.4
7.2
431
3380
H66
ICD-10 Finland
Suppurative and unspecified otitis media
3.3
7.2
34
105
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
7.3
7.2
16
22
XCH00
NOMESCO Finland
Eye pressure measurement
2.6
7.2
50
197
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
7.2
96
512
H26.02
ICD-10 Finland
Presenil cataract
3.0
7.1
38
128
X57
ICD-10 Finland
Unspecified privation
3.1
7.1
36
117
C10AA07
ATC
rosuvastatin; oral
1.5
7.1
253
1790
M03BX01
ATC
baclofen; systemic
3.7
7.1
29
80
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
5.7
7.1
19
34
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.5
7.0
53
219
SPAT1312
SPAT
General health counselling
0.7
7.0
202
2823
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.0
7.0
37
124
F01
ICPC
Eye pain
2.9
7.0
41
146
H60
ICD-10 Finland
Otitis externa
2.5
7.0
52
213
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.1
6.9
71
340
EB1WA
NOMESCO Finland
NA
6.4
6.9
17
27
S01FA02
ATC
scopolamine; ophthalmic
5.5
6.9
19
35
U01
ICPC
Dysuria/painful urination
2.0
6.9
88
459
M54.2
ICD-10 Finland
Cervicalgia
2.0
6.9
82
419
K59.1
ICD-10 Finland
Functional diarrhoea
2.2
6.9
68
320
K02.9
ICD-10 Finland
Dental caries, unspecified
3.8
6.9
27
72
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
6.9
205
1393
SPAT1310
SPAT
Counselling related to known health issue
0.7
6.9
198
2768
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.5
6.9
219
1512
T78.4
ICD-10 Finland
Allergy, unspecified
2.3
6.8
60
267
D07AA02
ATC
hydrocortisone; topical
1.7
6.8
157
997
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
6.8
121
711
R1250
NOMESCO Finland
Evaluation of functional capability
3.5
6.8
30
88
N03AF01
ATC
carbamazepine; oral, rectal
2.1
6.8
72
349
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.6
6.8
45
174
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
4.0
6.8
25
63
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
6.8
47
184
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
4.7
6.7
21
45
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
2.8
6.7
40
145
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.5
6.7
48
194
WX320
NOMESCO Finland
Spinalanesthesy
1.5
6.7
252
1801
CG2Z4
NOMESCO Finland
Specialised imaging of cornea
22.6
6.7
9
*
D06BB03
ATC
aciclovir; topical
2.2
6.7
65
307
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.1
6.6
71
347
A02BC03
ATC
lansoprazole; oral
1.4
6.6
334
2532
EAV
NOMESCO Finland
NA
3.8
6.6
26
70
IAB11
NOMESCO Finland
Psychiatric mood consultation
12.3
6.6
11
9
A06AD11
ATC
lactulose; oral
1.6
6.6
168
1097
D22
ICD-10 Finland
Melanocytic naevi
2.4
6.6
53
228
H26.4
ICD-10 Finland
After-cataract
1.8
6.6
115
673
M01AG02
ATC
tolfenamic acid; oral, rectal
1.6
6.6
184
1229
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
6.5
491
3989
R13
ICD-10 Finland
Dysphagia
2.0
6.5
79
405
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
10.1
6.5
12
12
A01
ICPC
Pain general/multiple sites
1.9
6.5
91
493
XKD00
NOMESCO Finland
Uroflowmetry
1.6
6.5
160
1035
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
3.6
6.5
27
76
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
5.1
6.5
19
38
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
2.4
6.5
52
222
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.5
6.5
21
47
H01
ICPC
Ear pain/earache
1.8
6.5
118
701
WX890
NOMESCO Finland
Intesive care monitoring
6.2
6.5
16
26
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
6.5
77
395
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
6.5
326
2473
N06AB10
ATC
escitalopram; oral
1.5
6.5
221
1547
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.8
6.5
111
648
ZX120
NOMESCO Finland
Intravenous
1.8
6.4
109
634
R03BA01
ATC
beclometasone; inhalant
1.6
6.4
168
1105
H15.0
ICD-10 Finland
Scleritis
14.4
6.4
10
7
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.3
6.4
29
88
N89
ICPC
Migraine
2.7
6.4
39
145
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.7
6.4
39
145
M01AB55
ATC
diclofenac, combinations; oral
1.9
6.4
88
477
H10
ICD-10 Finland
Conjunctivitis
2.0
6.3
78
405
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.8
6.3
38
139
R06AX13
ATC
loratadine; oral
1.6
6.3
179
1199
U02
ICPC
Urinary frequency/urgency
1.6
6.3
158
1025
M01AE02
ATC
naproxen; oral, rectal
1.3
6.3
669
5733
K07.60
ICD-10 Finland
Snapping jaw
2.2
6.3
62
293
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.8
6.3
108
630
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.0
6.3
23
58
SPAT1153
SPAT
Removal of sutures
0.7
6.3
192
2663
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
6.3
371
2893
N06AA09
ATC
amitriptyline; systemic
1.7
6.3
123
748
37700
ICD-8 Finland
Other diseases of retina and optic nerve, Haemorrhagia corporis vitrei
+∞
6.3
6
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
6.2
111
655
D01AE16
ATC
amorolfine; topical
1.7
6.2
131
813
A29
ICPC
General symptom/complaint other
1.7
6.2
129
795
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.1
6.2
62
296
TUPEI
NOMESCO Finland
NA
2.5
6.2
47
194
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.5
6.2
44
177
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.6
6.1
41
160
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
3.4
6.1
27
80
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.4
6.1
47
197
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
4.3
6.1
21
50
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
6.1
228
1624
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.7
6.1
110
652
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
4.7
6.1
19
41
R5140
NOMESCO Finland
Monitoring the use of the aid
1.7
6.1
111
661
92100
ICD-8 Finland
Contusion of eye and orbit, Current injury
8.6
6.1
12
14
WVA20
NOMESCO Finland
Medicine administration
3.2
6.0
29
92
CKC15
NOMESCO Finland
Panretinal photocoagulation
6.7
6.0
14
21
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
6.7
6.0
14
21
W19
ICD-10 Finland
Unspecified fall
1.8
6.0
100
576
R01AD05
ATC
budesonide; nasal
1.8
6.0
95
541
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3033658) Prothrombin time (PT) actual/Normal
665
2909
3.34
110.18
5.2
3.8
%
90.9
90.6
0.09
660
2829
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
457
1786
3.26
88.13
3.3
2.9
e6/l
2.8
2.9
0.11
202
971
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
334
1091
3.66
85.48
3.5
2.4
u/l
31.8
38.6
0.75
283
918
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
470
1911
3.14
84.20
3.3
2.7
e6/l
0.9
1.1
0.55
215
1090
(40758558) Short blood count panel - Blood
622
2982
2.88
82.32
7.6
6.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
608
3104
2.63
68.28
4.0
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
733
4098
2.57
67.98
5.0
3.6
e6/l
58.4
127.9
2.01
460
2910
(3030467) Casts [#/volume] in Urine by Automated count
599
3172
2.50
60.66
4.1
3.1
e6/l
0.4
0.4
0.27
418
2416
(3002582) Erythrocytes [#/volume] in Urine
628
3470
2.41
57.06
4.1
3.2
e6/l
36.3
83.4
1.52
440
2686
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
454
2195
2.54
54.92
4.6
3.7
ng/l
365.6
436.2
0.15
361
1681
(3018418) pH of Serum or Plasma
611
3417
2.35
53.08
5.0
3.9
ph
7.4
7.4
0.55
30
647
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
169
513
3.59
46.88
4.8
3.4
mmol/l
24.6
24.2
0.70
163
454
(42870588) Differential panel, method unspecified - Blood
650
3915
2.18
45.30
6.7
5.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
302
1316
2.63
44.25
2.7
2.5
umol/l
7.5
8.3
0.26
257
1133
(3022096) Basophils/100 leukocytes in Blood
797
5316
2.09
41.21
7.8
5.8
%
0.7
0.7
0.31
751
4940
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
418
2208
2.25
39.38
3.2
2.9
mmol/l
2.4
2.5
0.25
358
1932
(3052851) Hemolysis interference index of Serum or Plasma
125
348
3.83
39.23
3.1
3.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1241
9976
2.54
38.21
28.2
17.9
g/l
331.5
332.1
1.42
1227
9888
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
120
332
3.85
37.98
1.4
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
804
5489
2.02
37.74
7.8
5.8
%
2.9
2.8
0.24
757
5092
(3019069) Monocytes/100 leukocytes in Blood
804
5515
2.01
36.94
7.9
6.0
%
8.7
8.5
1.66
759
5148
(3018010) Neutrophils/100 leukocytes in Blood
809
5600
1.98
35.77
7.8
5.6
%
56.6
57.4
1.14
765
5226
(3000991) Gas panel - Venous blood
219
898
2.69
35.76
9.1
8.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
714
4737
1.98
35.68
2.4
2.0
pmol/l
97.1
95.2
0.45
339
2404
(3002385) Erythrocyte distribution width [Ratio]
1218
9808
2.39
35.62
27.4
16.7
%
13.7
13.7
0.17
1196
9582
(3002030) Lymphocytes/100 leukocytes in Blood
815
5681
1.97
35.03
7.8
5.9
%
28.3
27.9
0.56
767
5276
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
160
564
3.06
34.53
8.5
9.7
mmol/l
24.4
24.3
0.03
148
526
(3011397) Hemoglobin [Presence] in Urine by Test strip
465
2680
2.07
34.25
3.2
3.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
94
236
4.19
33.96
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
94
236
4.19
33.96
1.3
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
757
5191
1.94
33.66
9.3
9.2
e9/l
0.0
0.0
0.58
566
4250
(3001604) Monocytes [#/volume] in Blood
824
5818
1.94
33.51
7.9
5.6
e9/l
0.6
0.6
0.30
685
5028
(3006315) Basophils [#/volume] in Blood
823
5840
1.93
32.62
7.9
5.6
e9/l
0.0
0.0
0.01
686
5055
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
592
3797
1.93
31.58
3.5
3.1
u/l
30.3
32.8
1.07
558
3613
(3019198) Lymphocytes [#/volume] in Blood
834
6003
1.90
31.01
7.9
5.7
e9/l
1.9
1.9
0.14
720
5292
(3013650) Neutrophils [#/volume] in Blood by Automated count
916
6807
1.91
30.74
10.8
8.7
e9/l
3.9
4.1
1.44
763
5969
(3013115) Eosinophils [#/volume] in Blood
836
6053
1.88
30.18
8.3
5.9
e9/l
0.2
0.2
0.26
724
5305
(3024561) Albumin [Mass/volume] in Serum or Plasma
721
4994
1.87
29.82
5.3
4.5
g/l
35.8
35.5
0.62
668
4622
(3026782) Osmolality of Urine
400
2299
2.02
28.90
2.9
2.7
mosm/kgh2o
540.7
544.0
0.11
319
1975
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
741
5214
1.85
28.80
7.1
5.7
mmol/l
1.2
1.2
0.42
692
4697
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
101
318
3.34
26.20
2.3
2.5
g/l
0.0
0.0
0.00
92
294
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
101
320
3.31
25.94
2.3
2.5
g/l
0.0
0.0
0.00
92
295
(3031040) Bacteria [#/volume] in Urine by Automated count
989
7768
1.83
25.26
5.9
4.5
e6/l
7752.1
2124.4
0.59
13
120
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
782
5734
1.77
25.23
7.4
6.4
mmol/l
1.2
1.2
0.18
713
4814
(3014111) Lactate [Moles/volume] in Serum or Plasma
209
979
2.32
25.23
7.8
6.7
mmol/l
1.2
1.4
1.83
198
939
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
103
336
3.22
25.22
2.3
2.5
g/l
0.0
0.0
0.74
94
311
(3000850) Epithelial cells [#/volume] in Urine
406
2442
1.91
25.17
2.9
2.5
e6/l
5.3
6.6
1.02
351
2161
(3009542) Hematocrit [Volume Fraction] of Blood
1266
10814
2.20
24.96
27.2
14.8
%
40.0
39.6
1.39
1143
7813
(3036489) Thrombin time
118
425
2.93
24.36
2.1
1.8
s
21.6
21.2
0.24
104
376
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
103
349
3.10
23.66
2.3
2.4
g/l
38.3
38.1
0.13
93
304
(3024928) Oxygen saturation in Venous blood
78
233
3.48
21.97
3.3
2.7
—
—
—
0
0
(3044889) 12 lead EKG panel
1009
8132
1.76
21.83
4.1
3.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
105
377
2.92
21.78
2.3
2.6
g/l
0.9
1.1
0.13
95
334
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
418
2646
1.81
21.50
2.0
1.7
mg/l
1.8
1.1
0.81
310
2004
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
108
406
2.79
20.58
2.3
2.4
g/l
10.7
10.4
0.19
98
351
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
108
407
2.78
20.48
2.3
2.4
g/l
3.1
3.1
0.22
95
324
(3023410) Appearance of Cerebral spinal fluid
49
110
4.57
20.42
1.5
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
93
325
2.99
20.24
2.8
2.2
%
195.8
185.0
0.46
85
310
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
70
206
3.52
20.17
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
176
845
2.23
19.85
1.6
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
435
2.68
19.51
2.2
2.3
g/l
3.7
3.8
0.30
94
319
(3012095) Magnesium [Moles/volume] in Serum or Plasma
310
1838
1.87
19.46
3.1
3.1
mmol/l
0.8
0.8
0.43
285
1715
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
436
2.67
19.43
2.2
2.3
g/l
7.1
7.3
0.73
96
333
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
436
2.67
19.43
2.2
2.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
188
936
2.16
19.35
1.3
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
96
352
2.85
19.16
2.2
2.1
%
89.3
90.4
0.16
90
326
(1002224) Polysomnography panel
119
488
2.56
19.09
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
199
1018
2.10
19.08
4.5
3.4
mmol/l
2.2
1.9
0.54
168
804
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
96
355
2.82
18.86
1.3
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
644
4720
1.65
18.84
2.3
2.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
566
4028
1.66
18.50
3.1
3.3
mmol/l
2.4
2.4
0.22
500
3514
(3021960) Folate [Moles/volume] in Serum or Plasma
413
2703
1.73
18.48
1.7
1.5
nmol/l
21.4
20.8
0.41
377
2287
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
165
795
2.21
18.40
2.3
2.4
au/ml
28.5
21.1
—
10
51
(3021447) Carbon dioxide [Partial pressure] in Venous blood
198
1030
2.07
18.12
4.5
3.4
kpa
6.0
5.8
1.71
189
991
(3014765) Yersinia sp identified in Stool by Organism specific culture
95
357
2.78
18.11
1.3
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
664
4946
1.62
17.92
2.6
2.3
nmol/l
77.4
77.1
0.10
599
4437
(42529406) Shigella sp [Presence] in Stool by Culture
95
362
2.74
17.63
1.3
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
986
8110
1.65
17.58
5.5
4.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
362
2317
1.75
17.39
1.6
1.4
g/l
2.5
2.4
0.20
159
1419
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1074
9044
1.69
17.34
8.3
7.2
u/l
79.3
78.1
0.23
1002
8471
(3001122) Ferritin [Mass/volume] in Serum or Plasma
689
5207
1.61
17.32
3.4
2.8
ug/l
121.5
119.9
0.04
647
4796
(3000492) Spirometry study
208
1141
1.96
16.33
1.7
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
87
331
2.73
16.20
1.2
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
775
6100
1.57
15.84
5.6
6.0
umol/l
12.0
11.4
0.56
736
5771
(3014576) Chloride [Moles/volume] in Serum or Plasma
238
1406
1.83
14.79
8.2
6.5
mmol/l
104.1
104.3
0.18
232
1371
(3003458) Phosphate [Moles/volume] in Serum or Plasma
247
1480
1.80
14.64
7.4
5.3
mmol/l
1.1
1.0
0.97
230
1360
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
37
88
4.29
14.38
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
37
88
4.29
14.38
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
37
88
4.29
14.38
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
229
1349
1.83
14.34
1.7
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1244
11087
1.78
14.32
19.4
12.7
ml/min/173m2
83.6
81.5
2.30
1000
9121
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
136
670
2.13
14.28
2.1
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
223
1305
1.84
14.26
2.1
1.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
37
89
4.24
14.18
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
37
89
4.24
14.18
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
37
89
4.24
14.18
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
509
3717
1.56
13.99
2.7
2.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
28
54
5.27
13.93
2.9
3.1
u/ml
722.7
1054.4
0.61
28
54
(40768797) Stomach Pathology biopsy report
262
1623
1.75
13.80
1.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
223
1318
1.82
13.78
2.1
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1022
8710
1.56
13.61
4.6
4.0
mm/h
12.2
12.1
0.09
957
8023
(3017143) Hepatitis C virus Ab [Presence] in Serum
220
1301
1.81
13.56
1.9
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
39
101
3.94
13.56
1.5
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
254
1567
1.75
13.56
1.4
1.3
titre
338.4
504.6
1.74
50
330
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
434
3078
1.58
13.44
1.7
1.6
mmol/l
1.3
1.4
0.09
405
2602
(3048689) Calprotectin [Mass/mass] in Stool
237
1437
1.77
13.43
2.1
2.3
ug/g
194.4
126.7
0.33
191
1122
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
909
7592
1.51
12.93
3.8
3.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
190
3103
0.55
12.84
3.7
4.0
estimate
0.0
0.0
1.08
48
1063
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
244
1517
1.73
12.61
3.1
2.5
%
22.1
22.8
0.35
230
1303
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
168
933
1.90
12.60
2.6
2.9
ng/l
325.8
201.0
0.96
152
847
(3022948) Iron [Moles/volume] in Serum or Plasma
276
1776
1.68
12.57
2.8
2.4
umol/l
12.5
13.0
0.50
266
1635
(46235355) HIV 1 and 2 tests - Meaningful Use set
311
2068
1.64
12.46
2.0
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1295
11794
1.80
12.33
19.9
13.8
mg/l
25.4
23.1
1.59
1035
9304
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
60
1449
0.39
12.25
4.7
4.3
%
32.9
32.4
0.17
47
971
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
416
2983
1.55
12.05
2.3
2.1
mg/l
2.6
3.0
3.25
339
2532
(3024354) Oxygen [Partial pressure] in Venous blood
156
859
1.91
12.00
3.4
2.8
kpa
4.9
4.5
1.18
145
825
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
54
4.88
11.92
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
133
696
2.00
11.86
2.1
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
218
1337
1.74
11.79
2.0
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
378
2666
1.56
11.74
1.4
1.2
u/ml
1.8
1.6
0.09
53
720
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
47
152
3.16
11.74
1.8
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
85
375
2.34
11.66
2.5
1.7
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
17
24
7.15
11.43
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
79
341
2.39
11.39
3.3
2.8
u/ml
0.3
0.4
2.36
37
193
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
74
312
2.44
11.23
2.5
2.3
mg/l
12.3
11.8
0.25
67
284
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
391
2820
1.53
10.85
2.8
2.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
250
1628
1.64
10.75
2.9
2.4
g/l
2.2
2.3
3.93
236
1506
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
68
282
2.48
10.70
2.8
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
914
7795
1.45
10.59
3.3
3.0
u/l
42.9
47.4
0.84
857
7276
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
101
499
2.10
10.53
2.3
2.1
u/l
39.8
39.8
0.01
92
438
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
91
432
2.18
10.51
1.7
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
404
2956
1.51
10.41
2.7
2.5
umol/l
2664.9
6031.7
1.42
356
2551
(3020779) Urea [Moles/volume] in Serum or Plasma
164
961
1.79
10.33
7.6
7.1
mmol/l
10.4
9.4
0.77
155
917
(3051651) Icteric interference index of Serum or Plasma
29
74
3.98
10.33
3.7
3.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
50
182
2.81
10.20
1.3
1.2
u/ml
6.8
6.2
0.05
22
77
(3051611) Lipemic interference index of Serum or Plasma
38
118
3.28
10.17
3.9
3.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
20
38
5.32
10.12
2.6
2.8
—
—
—
0
0
(3013512) EKG study
225
3339
0.62
10.09
3.6
3.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
307
2131
1.56
10.05
1.7
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
56
221
2.59
9.78
1.4
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
34
101
3.42
9.76
1.3
1.1
titre
120.0
280.5
—
6
19
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
49
182
2.75
9.64
1.3
1.2
u/ml
4.8
4.1
0.06
21
52
(3024980) IgG subclass 4 [Mass/volume] in Serum
48
177
2.77
9.57
1.9
1.7
g/l
0.6
0.8
0.72
41
138
(3023368) Bacteria identified in Blood by Culture
414
3091
1.47
9.51
5.3
4.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
305
4190
0.66
9.51
2.5
2.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
154
908
1.78
9.49
5.3
3.7
ng/l
95.7
86.4
0.73
147
787
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
253
1703
1.59
9.42
1.7
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1200
10902
1.54
9.33
5.8
4.8
mu/l
3.5
2.0
0.43
1130
9982
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
108
572
1.96
9.32
9.0
10.8
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
126
703
1.87
9.30
9.7
8.7
%
1.2
1.4
1.52
126
698
(3042936) Bacteria identified in Isolate by Culture
245
1644
1.59
9.24
2.2
2.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
125
700
1.86
9.12
9.9
8.8
%
0.6
0.7
1.03
125
695
(3003396) Base excess in Arterial blood by calculation
198
1265
1.65
9.11
8.0
7.6
mmol/l
0.6
1.1
0.84
165
984
(3014007) Fractional oxyhemoglobin in Arterial blood
124
694
1.86
9.06
10.0
8.9
%
93.4
94.0
0.45
124
689
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
143
838
1.78
9.00
1.9
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
197
1264
1.64
8.91
8.1
7.6
kpa
5.1
5.1
0.33
186
1206
(3027801) Oxygen [Partial pressure] in Arterial blood
197
1265
1.64
8.88
8.1
7.6
kpa
12.3
12.1
0.16
186
1208
(3036603) Volume of Urine
28
78
3.64
8.85
1.4
1.5
—
2051.2
—
0
18
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
336
4476
0.68
8.80
3.3
3.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
454
3495
1.43
8.74
2.3
2.1
u/l
228.9
233.8
0.03
427
3285
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
103
550
1.94
8.69
1.9
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
107
580
1.91
8.63
1.5
1.3
iu/l
33.6
29.6
0.47
85
494
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
94
490
1.98
8.50
1.9
1.9
g/l
1.5
1.5
0.12
79
428
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
37
127
2.96
8.43
1.3
1.1
%
93.8
95.8
0.18
32
119
(3013826) Glucose [Moles/volume] in Serum or Plasma
794
6753
1.38
8.39
6.0
4.6
mmol/l
6.6
6.7
0.23
761
6306
(3019225) pH of Specimen
53
1158
0.44
8.39
4.9
4.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
58
251
2.36
8.38
1.4
1.4
e6/l
23.4
11.1
0.40
40
200
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
58
251
2.36
8.38
1.4
1.5
e6/l
336.8
831.1
0.45
41
206
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
44
167
2.68
8.34
1.2
1.1
%
118.6
116.5
0.21
37
154
(3026008) Bacteria identified in Urine by Culture
469
3657
1.41
8.33
3.6
3.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
75
1442
0.49
8.32
7.1
7.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
45
175
2.62
8.14
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
448
3483
1.41
8.04
3.2
3.1
mmol/l
7.0
7.4
1.18
383
2916
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
191
1248
1.61
8.01
3.2
4.1
u/l
250.0
252.0
0.04
181
1176
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
77
385
2.06
7.83
2.2
2.3
ug/l
1068.3
358.7
0.72
70
356
(3001964) Herpes simplex virus Ag [Presence] in Specimen
16
32
5.04
7.67
1.1
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
264
1874
1.50
7.62
2.1
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
147
912
1.68
7.55
2.3
2.9
g/l
65.6
66.9
1.00
131
831
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
46
188
2.49
7.54
1.0
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
283
2054
1.47
7.29
1.3
1.3
iu/ml
39.7
32.4
0.28
77
660
(40760892) CBC W Ordered Manual Differential panel - Blood
179
2625
0.64
7.29
3.4
4.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
111
644
1.78
7.24
1.3
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
89
483
1.90
7.19
1.3
1.5
u/ml
9.3
10.2
—
5
13
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
171
2517
0.64
7.06
1.6
1.7
pmol/l
469.3
23675850.3
2.26
155
2095
(3035637) Corticotropin [Mass/volume] in Plasma
32
113
2.87
6.97
1.4
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
57
3.72
6.92
1.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
38
150
2.57
6.72
1.8
1.7
—
—
—
0
0
(4306422)
41
169
2.47
6.64
1.4
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
189
1288
1.54
6.58
2.4
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
50
1012
0.48
6.43
4.2
3.8
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
23
70
3.32
6.43
1.1
1.1
iu/ml
14.5
12.2
—
6
20
(3003181) Sodium [Moles/volume] in Urine
47
210
2.28
6.38
1.3
1.4
mmol/l
58.0
62.8
0.32
35
170
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
17
42
4.08
6.36
1.1
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
44
192
2.33
6.31
1.1
1.1
—
—
—
0
0
(4268621)
32
120
2.70
6.27
2.6
2.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
54
259
2.13
6.18
1.1
1.2
mmol/l
3.8
3.8
0.06
48
242
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
78
427
1.87
6.17
3.3
3.4
u/ml
1647.8
3392.9
0.29
69
370
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
19
5.83
6.11
1.4
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
25
83
3.05
6.09
2.8
2.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47
948
0.48
5.99
2.6
3.6
mmol/l
1.2
1.2
0.00
36
814
(3021387) Prolactin [Units/volume] in Serum or Plasma
75
410
1.87
5.97
1.8
1.6
mu/l
423.6
299.3
0.88
69
372
(3041096) Erythrocytes [Presence] in Urine by Automated
236
3164
0.70
5.95
2.9
3.4
—
—
—
0
0
(4094501)
58
291
2.03
5.91
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
231
1676
1.45
5.90
3.1
3.0
ug/l
0.6
0.8
1.71
170
1079
(1761482) Bacteria [#/volume] in Urine by Culture
7
307
0.22
5.89
3.0
4.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
48
953
0.49
5.85
1.9
4.1
%
0.9
0.9
0.01
14
282
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
60
309
1.98
5.70
1.4
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1279
12052
1.46
5.69
22.9
15.8
mmol/l
139.4
139.6
2.07
1255
11718
(3023103) Potassium [Moles/volume] in Serum or Plasma
1282
12086
1.46
5.69
23.4
15.9
mmol/l
3.9
4.0
8.16
1257
11737
(3025159) Blasts/100 leukocytes in Blood
41
850
0.47
5.66
2.0
4.2
%
0.0
0.9
—
10
213
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
46
3.73
5.65
2.1
2.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1015
9226
1.32
5.64
4.5
4.1
pmol/l
14.4
14.8
4.19
945
8394
(3027945) Reticulocytes/100 erythrocytes in Blood
181
1269
1.49
5.50
2.3
2.6
%
1.8
1.8
0.11
163
1120
(3002179) Metamyelocytes/100 leukocytes in Blood
43
866
0.48
5.47
2.0
4.0
%
0.2
0.6
—
10
205
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
62
328
1.93
5.47
1.2
1.2
—
28.4
—
0
15
(3021440) Promyelocytes/100 leukocytes in Blood
46
903
0.49
5.43
1.9
4.2
%
0.1
0.1
0.32
14
256
(3013139) Helicobacter pylori Ag [Presence] in Stool
121
778
1.60
5.43
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
22
73
3.04
5.38
2.0
2.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
13
30
4.36
5.30
5.5
3.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
159
1095
1.51
5.27
2.6
2.2
g/l
0.2
0.2
1.54
147
1029
(3036071) Salmonella sp Ab [Titer] in Serum
15
39
3.88
5.27
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
44
208
2.15
5.27
1.5
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
58
304
1.95
5.26
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
27
103
2.65
5.16
1.1
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
24
86
2.82
5.15
1.7
1.9
%
12.1
10.6
0.64
24
86
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
32
133
2.44
5.15
1.5
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
19
5.29
5.04
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
21
71
2.99
4.99
1.2
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
114
739
1.59
4.96
2.6
3.3
pmol/l
4.2
4.5
2.96
99
647
(3019309) Folate [Moles/volume] in Red Blood Cells
285
2211
1.36
4.88
1.8
1.8
nmol/l
940.9
1200.5
5.99
204
1656
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
45
222
2.06
4.85
1.2
1.2
u/ml
282.0
251.9
0.23
35
129
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
9
10
9.05
4.78
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
47
237
2.02
4.78
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
38
177
2.18
4.74
1.8
2.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
63
352
1.83
4.74
1.4
1.5
ug/g
276.2
289.2
0.20
44
205
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
29
120
2.45
4.73
4.4
3.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
165
1173
1.46
4.68
2.1
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
181
1314
1.43
4.59
1.2
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
117
778
1.55
4.58
2.6
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
198
1467
1.40
4.48
1.3
1.3
—
—
—
0
0
(4062490)
27
111
2.46
4.48
1.2
1.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
19
65
2.95
4.45
1.6
1.4
u/l
10.1
13.9
1.88
19
60
(3049717) Cytology report of Urine Cyto stain
68
397
1.75
4.44
2.1
2.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
58
323
1.83
4.43
1.8
1.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
44
224
1.99
4.38
1.6
1.4
—
12.9
—
0
5
(3021601) Nitrite [Presence] in Urine by Test strip
658
5772
1.25
4.33
5.5
5.1
estimate
0.0
0.0
0.50
49
1092
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
90
571
1.61
4.31
2.1
2.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
656
5755
1.25
4.31
3.3
3.7
estimate
0.0
0.0
0.00
50
1085
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
10
22
4.57
4.30
1.2
1.1
%
101.5
98.2
—
10
22
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
22
4.57
4.30
1.2
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
56
960
0.57
4.28
3.3
3.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
140
983
1.47
4.24
2.1
2.4
ug/l
10.5
6.9
0.46
114
859
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
43
221
1.97
4.19
1.7
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1308
12502
1.41
4.19
13.2
10.1
u/l
25.7
26.0
0.28
1272
12056
(3048929) Epstein Barr virus Ab [Presence] in Serum
63
367
1.75
4.16
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
183
1356
1.40
4.14
2.0
1.7
%
1.4
1.5
0.30
161
1195
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
19
68
2.82
4.13
1.4
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
152
1093
1.44
4.07
2.5
2.0
nmol/l
397.7
377.1
0.39
140
995
(3008037) Lactate [Moles/volume] in Venous blood
8
264
0.30
3.98
3.8
3.1
mmol/l
1.3
1.5
—
8
259
(3011288) Drugs identified in Urine by Screen method
51
283
1.83
3.97
2.3
2.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
71
435
1.66
3.93
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
35
171
2.07
3.92
1.0
1.0
u/ml
2.9
1.8
0.49
11
74
(3009261) Glucose [Presence] in Urine by Test strip
659
5833
1.23
3.85
3.4
3.7
estimate
0.0
0.0
0.80
50
1057
(3016502) Oxygen saturation in Arterial blood
154
1124
1.41
3.81
9.0
8.0
%
95.4
95.6
0.15
154
1085
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
5
12.04
3.76
1.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
237
0.29
3.75
1.4
3.2
e9/l
6.8
4.4
—
7
237
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
238
0.29
3.74
1.1
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
387
3237
1.27
3.74
3.4
3.3
mg/l
191.7
307.6
0.37
255
2033
(40768443) Skin Pathology biopsy report
80
513
1.59
3.71
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
109
2.32
3.70
1.8
1.6
—
—
—
0
0
(4034850)
15
387
0.38
3.66
6.1
9.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
52
299
1.77
3.63
1.4
1.3
u/l
13.0
10.3
0.52
37
236
(4198724)
13
40
3.27
3.63
1.4
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
42
226
1.88
3.62
1.1
1.2
—
6.5
—
0
16
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
234
1.86
3.58
1.6
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
93
623
1.53
3.57
1.0
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
247
1962
1.31
3.56
1.3
1.3
u/ml
15.1
12.6
0.15
55
780
(3028026) IgM [Mass/volume] in Serum or Plasma
99
673
1.50
3.55
1.9
1.8
g/l
1.2
1.4
1.17
92
619
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
17
5.32
3.51
8.9
4.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
63
2.72
3.49
1.4
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
17
63
2.72
3.49
1.1
1.3
—
—
—
0
0
(4035726)
137
997
1.41
3.46
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
63
388
1.65
3.45
1.9
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
246
0.32
3.44
1.4
3.6
%
66.3
58.2
—
8
246
(3005719) IgG [Mass/volume] in Serum or Plasma
120
854
1.44
3.43
2.9
2.8
g/l
10.8
10.5
0.23
114
779
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
25
510
0.48
3.39
3.6
3.7
%
52.8
48.5
0.37
25
504
(3002619) Bacteria identified in Specimen by Culture
9
18
5.02
3.37
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
22
95
2.34
3.34
1.8
2.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
65
2.63
3.31
1.1
1.2
—
—
—
0
0
(3025315) Body weight
6
7
8.60
3.26
4.5
4.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
18
72
2.52
3.21
1.1
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
187
1452
1.33
3.17
35.6
24.7
inr
1.4
1.3
0.29
16
189
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
59
366
1.64
3.17
1.3
1.6
iu/ml
0.0
0.1
1.03
14
71
(3028300) Cannabinoids [Presence] in Urine
67
430
1.58
3.14
1.9
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
29
546
0.52
3.11
2.7
3.3
mmol/l
25.7
25.1
0.56
29
527
(3005011) Chlamydia sp Ab [Titer] in Serum
9
20
4.52
3.11
1.9
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
34
3.25
3.06
1.2
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
66
426
1.58
3.03
1.9
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
66
427
1.57
3.00
1.9
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
66
427
1.57
3.00
1.9
1.7
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
5
10.03
2.98
1.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
12
40
3.02
2.97
2.8
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
406
0.46
2.97
1.6
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
11
35
3.16
2.93
1.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
28
142
1.99
2.91
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
52
321
1.64
2.87
1.4
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
519
4592
1.20
2.81
9.2
9.0
inr
1.2
1.2
0.05
89
1336
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
59
2.56
2.79
1.5
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
59
2.56
2.79
1.5
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
117
2.07
2.78
1.1
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
6
8.36
2.75
1.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
14
5.02
2.73
12.7
6.5
mmol/l
4.0
7.1
—
7
14
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1125
10688
1.22
2.72
6.4
5.6
mmol/mol
39.6
39.7
0.08
1075
9901
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
25
125
2.02
2.71
2.2
2.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
25
125
2.02
2.71
1.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
10
6.02
2.70
1.5
2.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
32
3.14
2.65
1.2
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
10
32
3.14
2.65
1.9
1.8
—
—
—
0
0
(3020891) Body temperature
24
453
0.52
2.64
4.3
4.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
21
413
0.50
2.62
3.9
3.7
mmol/l
1.8
1.4
0.51
21
405
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
24
449
0.53
2.57
5.8
6.1
%
2.2
1.6
1.79
24
423
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
7
7.16
2.55
3.6
3.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
24
447
0.53
2.54
5.8
6.1
%
1.0
0.9
0.60
24
420
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
56
2.51
2.53
1.3
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
393
3420
1.20
2.50
4.1
4.0
mg/mmol
14.5
9.4
0.87
239
2134
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
217
1.72
2.50
6.5
5.4
iu/ml
2314.6
387.6
—
5
28
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
52
334
1.58
2.48
1.2
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
32
180
1.80
2.48
1.1
1.1
u/ml
0.4
7.3
4.78
19
93
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
159
0.31
2.42
2.4
2.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
83
2.18
2.41
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
131
1.92
2.41
1.2
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
25
131
1.92
2.41
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
111
2.00
2.36
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
65
2.32
2.32
1.1
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
59
2.39
2.29
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
53
2.47
2.28
1.2
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
20
99
2.03
2.26
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
110
835
1.34
2.23
1.2
1.2
iu/ml
129.7
144.9
0.09
22
326
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
172
1.76
2.22
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
80
2.14
2.19
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
48
2.51
2.19
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
32
188
1.72
2.18
1.2
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
14
4.30
2.15
1.3
2.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
11
43
2.57
2.10
1.9
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
62
2.27
2.08
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
62
2.27
2.08
1.1
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
47
696
0.66
2.05
1.8
3.3
mmol/l
1.6
1.9
0.25
33
521
(3007461) Platelets [#/volume] in Blood
1346
13128
1.29
2.05
29.3
20.3
e9/l
250.2
252.6
0.69
1302
12778
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1182
11375
1.20
2.04
5.0
4.4
mmol/l
6.0
5.9
0.75
1100
10319
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
160
0.37
2.02
1.3
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
44
2.51
2.01
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
21
111
1.90
2.01
1.0
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
14
63
2.23
2.01
14.1
7.2
u/ml
43.8
41.9
—
6
18
(21494890) Protein electrophoresis panel - 24 hour Urine
20
104
1.94
2.01
1.8
2.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
19
97
1.97
2.00
1.1
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
84
1117
0.74
2.00
1.4
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
38
240
1.60
2.00
2.5
3.1
umol/l
31.3
34.9
0.51
33
201
(3024731) MCV [Entitic volume]
1346
13135
1.28
1.98
29.3
20.2
fl
91.3
90.9
2.68
1327
12927
(3035941) MCH [Entitic mass]
1346
13137
1.28
1.96
29.3
20.2
pg
30.4
30.2
1.33
1326
12928
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
24
134
1.80
1.96
1.1
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1346
13138
1.28
1.95
29.3
20.3
e12/l
4.5
4.5
1.03
1300
12759
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
51
347
1.49
1.94
2.4
2.9
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
11
45
2.46
1.93
45.6
27.5
ug/l
7.4
7.4
0.02
11
39
(3025941) Bacteria identified in Stool by Culture
88
662
1.35
1.92
1.3
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
46
307
1.51
1.92
2.2
1.9
iu/l
2.4
5.4
3.33
15
106
(3010813) Leukocytes [#/volume] in Blood
1346
13142
1.28
1.92
29.4
20.3
e9/l
6.7
6.8
0.32
1300
12753
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
51
732
0.69
1.92
1.8
3.3
kpa
5.0
5.2
0.96
46
684
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
399
4458
0.86
1.91
3.8
3.5
ng/l
1653.4
45.4
0.53
204
3015
(3000963) Hemoglobin [Mass/volume] in Blood
1346
13144
1.27
1.90
29.5
20.4
g/l
133.6
134.6
1.78
1327
12933
(40761511) CBC panel - Blood by Automated count
1270
12325
1.22
1.89
14.5
13.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
31
189
1.65
1.88
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
31
189
1.65
1.88
1.1
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
12
4.18
1.82
1.0
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
93
713
1.32
1.81
2.3
2.2
nmol/l
13.8
12.9
0.48
83
636
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
17
87
1.97
1.80
1.1
1.2
mg/l
58.2
32.5
0.74
17
69
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
143
1161
1.26
1.79
3.2
4.1
ug/l
18.9
22.0
0.07
103
953
(3019150) Specific gravity of Urine by Refractometry
220
2567
0.83
1.76
3.0
4.1
kg/l
1.0
1.0
0.32
22
359
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
29
178
1.64
1.73
1.1
1.1
u/ml
0.2
0.8
1.79
15
71
(3036048) Francisella tularensis Ab [Titer] in Serum
7
24
2.93
1.72
1.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
13
3.86
1.71
1.6
1.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
15
75
2.01
1.70
1.2
1.3
—
49.1
—
0
11
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
34
219
1.57
1.69
1.5
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
596
5505
1.14
1.67
4.0
4.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
16
83
1.94
1.65
1.5
1.8
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
19
106
1.80
1.59
1.1
1.3
e6/l
3988.7
96950.5
—
8
59
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
50
2.21
1.57
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
11
50
2.21
1.57
1.0
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
28
177
1.59
1.52
1.4
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
260
2281
1.17
1.49
4.3
4.2
%
24.5
21.1
1.66
93
1066
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
116
1.73
1.49
1.2
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
229
1989
1.18
1.49
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
33
219
1.52
1.47
1.5
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
95
755
1.28
1.46
1.3
1.3
u/ml
207.7
202.7
0.02
87
692
(3005033) Fetal Nuchal fold Thickness US
32
212
1.52
1.44
1.5
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
60
448
1.35
1.43
2.1
1.7
mg/l
2.3
4.2
0.72
45
316
(4281824)
22
133
1.66
1.43
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
32
213
1.51
1.41
1.5
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
39
271
1.45
1.40
2.2
2.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
35
238
1.48
1.40
1.9
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
178
0.50
1.40
1.6
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
179
0.50
1.40
1.4
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
46
331
1.40
1.38
1.1
1.1
u/ml
2.7
5.8
—
5
44
(1616796) Gas panel - Central venous blood
14
249
0.56
1.38
2.2
3.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
20
119
1.69
1.38
1.1
1.3
e6/l
1373.8
1812.3
—
10
79
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
20
119
1.69
1.38
1.5
1.2
u/l
59.2
53.3
0.27
14
84
(3028433) Virus identified in Specimen by Culture
9
41
2.20
1.37
1.2
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
26
167
1.57
1.35
1.1
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
18
105
1.72
1.33
1.1
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
31
208
1.50
1.33
1.1
1.1
u/ml
1.4
1.6
0.07
16
84
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
219
0.54
1.30
1.8
2.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
21
129
1.64
1.30
1.1
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
35
2.29
1.27
1.6
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
35
2.29
1.27
1.1
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
35
2.29
1.27
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
204
0.54
1.26
1.8
2.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
68
529
1.30
1.26
3.5
2.5
%
0.5
0.7
3.48
68
508
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
151
1285
1.20
1.26
1.9
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
36
2.23
1.24
1.9
2.0
—
—
—
0
0
(3024471) HLA-A [Type]
8
36
2.23
1.24
1.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
11
56
1.97
1.22
1.4
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
19
2.64
1.21
1.4
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
40
289
1.39
1.20
1.5
1.8
nmol/l
45.2
40.0
0.68
40
276
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
33
464
0.70
1.19
1.8
3.6
mmol/l
25.2
25.0
0.18
33
436
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
26
2.31
1.18
1.3
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
26
2.31
1.18
1.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1206
11761
1.14
1.16
5.7
4.8
mmol/l
2.7
2.8
1.35
1146
10812
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
34
0.00
1.16
0.0
1.1
—
30.3
—
0
28
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
20
2.50
1.15
1.0
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
20
2.50
1.15
1.2
1.1
—
—
—
0
0
(4010399)
98
810
1.22
1.12
1.4
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
15
88
1.71
1.11
1.3
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
256
0.62
1.10
2.8
3.7
mg/l
21.4
26.0
—
9
163
(3047181) Lactate [Moles/volume] in Blood
24
350
0.68
1.08
5.8
7.4
mmol/l
1.2
1.4
0.28
24
300
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
454
0.72
1.07
2.3
1.9
—
—
—
0
0
(4027681)
13
74
1.76
1.07
1.1
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
357
3277
1.12
1.06
2.7
3.0
ng/l
2226.0
1400.0
0.86
302
2772
(3010726) Horse dander IgE Ab [Units/volume] in Serum
26
178
1.47
1.05
1.1
1.0
u/ml
0.4
4.1
—
8
39
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
48
367
1.32
1.04
1.4
1.3
miu/ml
237.3
239.9
0.02
19
176
(3015235) Bicarbonate [Moles/volume] in Capillary blood
19
286
0.66
1.01
2.0
2.6
mmol/l
24.4
25.0
0.19
14
249
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
29
0.00
0.97
0.0
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
59
736
0.79
0.97
4.0
5.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
51
398
1.29
0.97
3.4
3.2
g/l
0.5
0.3
0.40
35
170
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
14
85
1.65
0.94
1.5
1.6
g/l
0.9
1.0
0.84
14
85
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
101
1.59
0.93
1.6
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
16
245
0.65
0.93
7.2
8.7
mmol/l
11.1
11.4
0.14
16
222
(3018572) Chloride [Moles/volume] in Blood
16
245
0.65
0.93
7.2
8.7
mmol/l
105.8
105.2
0.25
16
222
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
196
0.61
0.92
1.4
1.6
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
5
101
0.49
0.89
1.2
1.2
nmol/l
495.2
381.9
—
5
88
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
42
1.91
0.88
1.1
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
72
1.67
0.85
4.9
7.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
31
412
0.75
0.85
2.1
1.8
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
8
46
1.74
0.82
1.1
1.2
g/l
0.3
0.3
—
8
40
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
35
267
1.32
0.81
1.5
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
42
531
0.78
0.81
1.9
3.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
47
1.71
0.80
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
21
147
1.43
0.80
2.9
3.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
48
596
0.80
0.80
2.4
3.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
35
268
1.31
0.79
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
35
268
1.31
0.79
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
35
268
1.31
0.79
1.5
1.4
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
24
0.00
0.79
0.0
6.6
—
74.9
—
0
19
(3044927) Protein electrophoresis panel - Urine
7
122
0.57
0.78
1.6
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
18
257
0.70
0.77
1.6
2.6
kpa
7.6
8.0
0.54
13
237
(3019832) Treponema pallidum Ab [Presence] in Serum
121
1061
1.15
0.77
1.6
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
34
1.77
0.76
1.2
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
24
2.09
0.74
1.2
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
24
2.09
0.74
1.0
1.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
39
1.80
0.72
1.9
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
159
0.63
0.72
1.3
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
19
134
1.42
0.71
1.1
1.4
g/l
31.1
32.3
0.12
12
116
(3050129) First trimester maternal screen panel - Serum or Plasma
25
332
0.75
0.71
1.5
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
77
1.56
0.68
1.5
1.5
u/l
38.7
7.8
—
6
37
(3012501) Base excess in Blood by calculation
18
250
0.72
0.68
2.7
4.0
mmol/l
3.2
2.7
0.26
11
171
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
24
179
1.35
0.67
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
191
0.68
0.67
1.3
1.3
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
13
86
1.52
0.66
1.1
1.1
mg/l
261.4
226.5
0.43
13
72
(3042631) Mycobacterium sp identified in Specimen
10
155
0.64
0.66
2.4
3.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
40
492
0.81
0.64
1.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
129
0.62
0.64
1.0
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
18
130
1.39
0.61
1.3
2.0
umol/l
3.4
5.2
—
10
89
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
36
289
1.25
0.61
1.6
1.5
—
—
—
0
0
(3010421) pH of Blood
24
312
0.77
0.61
2.3
3.7
ph
7.4
7.4
0.12
18
247
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
20
0.00
0.60
0.0
8.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
141
0.64
0.60
2.1
2.0
pg
31.9
32.2
—
9
141
(3023520) Reticulocytes [#/volume] in Blood
103
913
1.14
0.60
2.0
2.6
e9/l
69.1
71.7
0.31
57
696
(3044941) Cell count panel - Synovial fluid
24
183
1.32
0.59
2.0
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
69
797
0.86
0.58
1.5
3.0
e9/l
4.3
4.1
0.25
60
623
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
53
1.51
0.58
1.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
26
203
1.29
0.56
1.9
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
102
909
1.13
0.56
2.5
2.6
ml/min/173m2
78.0
68.2
1.64
44
371
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
123
0.65
0.54
2.8
4.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
34
416
0.81
0.54
1.7
1.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
19
249
0.76
0.53
1.6
2.0
g/l
117.1
129.3
—
8
182
(3004616) Nuclear Ab [Presence] in Serum
9
133
0.67
0.52
1.7
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
100
0.60
0.51
1.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
100
0.60
0.51
1.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
100
0.60
0.51
1.0
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
382
3638
1.07
0.51
2.8
2.5
u/l
54.9
56.2
0.35
353
3359
(40768806) Pleura Pathology biopsy report
15
109
1.38
0.51
1.7
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
303
2863
1.07
0.51
5.0
4.8
ug/l
2.1
2.8
0.99
269
2538
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
144
1.32
0.50
1.2
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
78
689
1.14
0.50
3.4
3.0
g/l
131.6
127.6
0.92
78
674
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
132
1204
1.11
0.50
3.6
3.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
28
226
1.24
0.48
1.4
1.2
—
—
—
0
0
(4146454)
8
119
0.67
0.45
2.0
2.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
125
1145
1.10
0.45
1.5
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
31
1.61
0.43
3.4
2.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
20
251
0.79
0.42
1.1
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
206
0.77
0.41
1.3
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
16
0.00
0.41
0.0
2.8
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
16
0.00
0.41
0.0
2.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
149
0.74
0.40
1.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
149
0.74
0.40
1.2
1.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
27
223
1.21
0.39
2.7
3.6
u/ml
27.0
29.1
0.10
27
216
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
270
0.81
0.39
1.4
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
35
1.43
0.39
2.8
2.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
147
0.75
0.37
1.2
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
147
0.75
0.37
1.2
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
37
1.35
0.37
2.0
1.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
5
37
1.35
0.37
1.2
1.7
pmol/l
16.6
14.5
—
5
30
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
115
0.69
0.37
1.0
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
169
0.77
0.37
1.4
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
134
1.27
0.37
1.2
1.3
nmol/l
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
278
0.82
0.36
1.3
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
146
0.75
0.36
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
146
0.75
0.36
1.2
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
12
90
1.34
0.36
1.1
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
19
153
1.24
0.35
1.3
1.3
mmol/l
7.7
7.3
0.16
12
108
(3005570) Glucose [Moles/volume] in Urine
9
126
0.71
0.35
1.4
2.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
21
172
1.22
0.34
1.3
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
112
1038
1.09
0.34
1.7
1.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
145
1.24
0.33
1.0
1.1
u/ml
7.0
3.3
—
10
54
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
34
392
0.86
0.33
2.8
2.2
u/l
657.8
2524.1
1.56
11
161
(3001019) Free T4 and TSH panel - Serum or Plasma
73
664
1.10
0.33
1.7
1.8
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
11
83
1.33
0.32
2.1
1.4
promille
0.6
1.1
0.80
11
63
(3039443) Prostate specific Ag panel - Serum or Plasma
14
175
0.80
0.31
1.9
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
93
1.29
0.30
1.3
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1159
11475
1.05
0.29
4.6
4.3
mmol/l
1.5
1.5
1.22
1094
10538
(3006653) Thiamine [Moles/volume] in Blood
8
63
1.27
0.27
1.1
1.3
nmol/l
158.3
146.3
—
8
63
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
71
0.70
0.26
1.8
1.8
u/field
2.4
2.3
—
5
55
(44790047)
16
133
1.21
0.24
1.4
1.6
—
—
—
0
0
(44806118)
16
133
1.21
0.24
1.4
1.6
—
—
—
0
0
(44790048)
16
133
1.21
0.24
1.4
1.6
—
—
—
0
0
(44790049)
16
133
1.21
0.24
1.4
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
33
293
1.13
0.24
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
97
1.24
0.23
1.1
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
39
1.28
0.23
1.6
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
39
1.28
0.23
1.6
2.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
40
1.25
0.22
1.0
1.2
pmol/l
163.8
291.0
—
5
28
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
41
1.22
0.22
1.4
2.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1165
11560
1.04
0.21
4.7
4.3
mmol/l
4.6
4.7
2.09
1110
10686
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
38.0
—
0
6
(3001729) Color of Synovial fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.0
—
10.8
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
102
0.78
0.21
1.9
2.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
13
0.00
0.21
0.0
1.2
—
6.9
—
0
8
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
13
0.00
0.21
0.0
5.9
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.1
—
30.7
—
0
9
(46235168) Fasting glucose [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.7
—
6.6
—
0
6
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
14
0.00
0.20
0.0
2.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
48
1.25
0.20
1.8
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
49
1.23
0.20
4.5
3.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
28
252
1.11
0.18
3.0
4.0
—
—
—
0
0
(3035880) pH of Pleural fluid
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
204
0.88
0.16
1.3
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
73
1.10
0.15
1.0
1.0
—
—
—
0
0
(44813793)
6
80
0.75
0.15
1.0
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
74
702
1.06
0.15
1.3
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
10
119
0.84
0.15
7.8
7.1
mmol/l
7.9
7.3
—
10
95
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
197
1.12
0.15
1.6
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
328
3212
1.03
0.15
1.4
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
28
305
0.92
0.14
1.1
1.3
—
—
—
0
0
(4024509)
8
100
0.80
0.13
2.0
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
30
278
1.08
0.12
2.0
1.7
e6/l
9202.0
14367.5
0.72
22
203
(3008295) Osmolality of Serum or Plasma
16
144
1.11
0.10
2.5
1.4
mosm/kgh2o
297.6
279.2
—
9
108
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
45
1.11
0.09
1.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
12
106
1.13
0.09
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
106
1.13
0.09
2.1
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
11
97
1.14
0.09
1.8
2.0
—
1.4
—
0
7
(3022621) pH of Urine by Test strip
76
786
0.97
0.09
3.1
2.9
—
—
—
0
0
(4211845)
6
56
1.07
0.08
4.5
2.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
144
0.90
0.08
1.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
5
61
0.82
0.08
1.8
3.5
—
7.4
—
0
16
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
61
0.82
0.08
1.0
1.1
—
16.3
—
0
8
(3017704) Immunofixation for Urine
5
64
0.78
0.08
1.2
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
65
0.77
0.08
1.0
2.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
7
68
1.03
0.07
1.0
1.0
ng/l
54.7
44.3
—
7
39
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
7
68
1.03
0.07
1.0
1.0
ng/l
413.6
293.1
—
7
42
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
36
378
0.95
0.07
1.1
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
81
0.86
0.07
1.7
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
80
0.87
0.07
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
82
0.85
0.07
1.7
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
17
157
1.08
0.07
1.0
1.0
u/ml
11.9
3.8
—
8
54
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
132
0.91
0.06
1.4
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
104
0.86
0.06
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
315
0.95
0.06
1.7
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
28
268
1.05
0.04
1.8
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
160
0.94
0.04
1.3
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
29
280
1.04
0.03
2.2
2.4
ug/min
216.8
134.2
0.23
18
171
(3032773) Endomysium IgG Ab [Titer] in Serum
12
112
1.07
0.03
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
49
500
0.98
0.02
2.1
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1108
11096
0.99
0.02
4.1
3.8
mmol/l
1.3
1.3
0.00
1029
10127
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
11
103
1.07
0.02
1.8
1.3
u/ml
0.2
0.7
—
6
44
(40768795) Lymph node Pathology biopsy report
10
107
0.93
0.02
1.4
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
72
711
1.01
0.01
1.4
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
10
102
0.98
0.00
1.1
1.3
nmol/l
1.8
1.4
—
10
90
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
41
411
1.00
0.00
1.3
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
56
0.89
0.00
1.0
1.6
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
2.2
—
0
5
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
180.6
—
0
8
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
9
97
0.93
0.00
1.1
1.0
mg/l
321.3
287.8
—
9
85
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.7
—
2.3
—
0
6
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
34.2
—
0
7
(4038314)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
7
72
0.97
0.00
2.0
2.1
ug/l
1.8
3.3
—
7
65
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
8.1
—
0
5
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
88
0.91
0.00
1.3
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
65
0.92
0.00
1.3
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
65
0.92
0.00
1.3
1.2
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
51
0.98
0.00
3.0
1.6
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_EYEADNEXOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_EYEADNEXOTH | 1.196 [1.08, 1.33] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.114 |
During the follow-up period (1.1.1998 — 31.12.2019), 690 out of 4383 females with H7_EYEADNEXOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_EYEADNEXOTH | 1.306 [1.15, 1.49] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.022 |
During the follow-up period (1.1.1998 — 31.12.2019), 533 out of 3224 males with H7_EYEADNEXOTH died.
Mortality risk
Mortality risk for people of age
years, who have H7_EYEADNEXOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.113% | 0.234% |
| 5 | 0.623% | 1.597% |
| 10 | 1.492% | 3.945% |
| 15 | 2.92% | 7.62% |
| 20 | 5.275% | 13.355% |
Relationships between endpoints
↥Index endpoint: H7_EYEADNEXOTH – Other specified and unspecified disorders of eye and adnexa
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data